The Babraham Research Campus is home to over 60 bioscience organisations and the world renowned Babraham Institute. The current success of the Campus is underpinned by a shared focus in the science and innovation themes undertaken by the companies and academic researchers on site. The Campus research community is delivering research and innovation with a focus on key questions in biology that resonate with the Campus’ commercial community, with global investors, and society more widely. Want to be part of this innovative, exciting community? Explore current vacancies below:
13 January 2022
BioNTech and Crescendo Biologics today announced that they have entered a multi-target discovery collaboration to develop novel immunotherapies for the treatment of patients with cancer and other diseases.
13 January 2022
PetMedix™ is pleased to announce a collaboration with Zoetis to develop novel, fully species-specific companion animal monoclonal antibody therapeutics (mAbs) using PetMedix’s proprietary transgenic platforms.
14 December 2021
The Council is proposing to make changes to the speed limits and traffic calming measures on High Street, Babraham.
Babraham Investor Conference 2021 (BIC), an event for investors focusing on early-stage and scale-up life science and med-tech companies, moved online for the first time in its 15-year history on 9 June. The virtual conference saw a day’s worth of content condensed into two hours including start-up and scale-up company presentations, keynotes from Daniel Mahony of Polar Capital and Martin Murphy of Syncona, as well as many interactive Q&A opportunities.